Danaher Corporation (DHR) Shares Bought by Lee Danner & Bass Inc.
Lee Danner & Bass Inc. boosted its position in shares of Danaher Corporation (NYSE:DHR) by 0.4% during the first quarter, Holdings Channel reports. The institutional investor owned 2,635 shares of the conglomerate’s stock after buying an additional 10 shares during the period. Lee Danner & Bass Inc.’s holdings in Danaher Corporation were worth $225,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently added to or reduced their stakes in DHR. Motco raised its stake in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock worth $158,000 after buying an additional 390 shares in the last quarter. Baystate Wealth Management LLC raised its stake in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock worth $163,000 after buying an additional 60 shares in the last quarter. Integrated Investment Consultants LLC raised its stake in Danaher Corporation by 22.1% in the first quarter. Integrated Investment Consultants LLC now owns 2,168 shares of the conglomerate’s stock worth $185,000 after buying an additional 393 shares in the last quarter. Cedar Wealth Management LLC raised its stake in Danaher Corporation by 5.3% in the first quarter. Cedar Wealth Management LLC now owns 2,286 shares of the conglomerate’s stock worth $196,000 after buying an additional 115 shares in the last quarter. Finally, ARP Americas LLC purchased a new stake in Danaher Corporation during the fourth quarter worth $202,000. Institutional investors and hedge funds own 77.44% of the company’s stock.
Danaher Corporation (DHR) opened at 84.48 on Friday. The stock has a market cap of $58.64 billion, a P/E ratio of 25.75 and a beta of 1.02. Danaher Corporation has a 12-month low of $73.42 and a 12-month high of $88.01. The company has a 50 day moving average of $83.96 and a 200-day moving average of $83.13.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings results on Thursday, April 20th. The conglomerate reported $0.85 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.84 by $0.01. Danaher Corporation had a net margin of 12.30% and a return on equity of 11.82%. The company had revenue of $4.21 billion for the quarter, compared to the consensus estimate of $4.17 billion. During the same quarter in the prior year, the company earned $1.08 EPS. Danaher Corporation’s quarterly revenue was up 7.2% on a year-over-year basis. Equities analysts forecast that Danaher Corporation will post $3.92 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 28th. Investors of record on Friday, June 30th will be issued a $0.14 dividend. The ex-dividend date is Wednesday, June 28th. This represents a $0.56 annualized dividend and a yield of 0.66%. Danaher Corporation’s dividend payout ratio (DPR) is presently 17.02%.
WARNING: “Danaher Corporation (DHR) Shares Bought by Lee Danner & Bass Inc.” was first reported by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://www.watchlistnews.com/danaher-corporation-dhr-shares-bought-by-lee-danner-bass-inc/1371832.html.
DHR has been the subject of a number of analyst reports. Zacks Investment Research upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $96.00 price objective for the company in a research note on Tuesday, April 4th. Vetr upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $95.50 price objective for the company in a research note on Monday, February 27th. Citigroup Inc. upgraded shares of Danaher Corporation from a “neutral” rating to a “buy” rating and set a $98.00 price objective for the company in a research note on Friday, February 24th. Credit Suisse Group restated a “buy” rating and set a $93.00 price objective on shares of Danaher Corporation in a research note on Wednesday, May 24th. Finally, BTIG Research restated a “buy” rating and set a $92.00 price objective on shares of Danaher Corporation in a research note on Sunday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. Danaher Corporation has an average rating of “Buy” and an average price target of $92.29.
In related news, insider Thomas Patrick Joyce, Jr. sold 54,006 shares of the stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $82.52, for a total value of $4,456,575.12. Following the transaction, the insider now owns 142,157 shares in the company, valued at approximately $11,730,795.64. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Donald J. Ehrlich purchased 600 shares of the business’s stock in a transaction that occurred on Friday, April 21st. The stock was acquired at an average price of $82.76 per share, for a total transaction of $49,656.00. Following the acquisition, the director now owns 84,800 shares in the company, valued at approximately $7,018,048. The disclosure for this purchase can be found here. In the last quarter, insiders sold 82,265 shares of company stock worth $6,815,839. 12.20% of the stock is owned by corporate insiders.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.